Luoxin Health Technology Development (Beijing) Co., Ltd. announced that it will receive CNY 127.90 million on September 14, 2022. The transaction will include participation from returning investors Deyi (Zhuhai) Capital Management Co., Ltd, and Luoxin Pharmaceuticals Group Stock Co., Ltd. The transaction has been approved by the 25th session of its 4th directorate, 21st session of its 4th supervisory board of the company. On closing Luoxin Health Technology Development (Beijing) Co., Ltd. stake will decrease from 83.33% to 51%.